CC
Caxton Corporation Portfolio holdings
AUM
$9.85M
1-Year Return
26.35%
This Quarter Return
+35.68%
1 Year Return
+26.35%
3 Year Return
+409.06%
5 Year Return
+527.59%
10 Year Return
+11,054.45%
AUM
$108M
AUM Growth
+$25.3M
(+31%)
Cap. Flow
+$4.79M
Cap. Flow
% of AUM
4.45%
Top 10 Holdings %
Top 10 Hldgs %
93.85%
Holding
31
New
6
Increased
10
Reduced
5
Closed
5
Top Buys
| 1 |
ABDC
Alcentra Capital Corp
ABDC
|
$5.44M |
| 2 |
KALA BIO
KALA
|
$1.19M |
| 3 |
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
|
$337K |
| 4 |
FerroAtlántica
GSM
|
$285K |
| 5 |
Mercado Libre
MELI
|
$221K |
Top Sells
| 1 |
Investcorp Credit Management BDC
ICMB
|
$1.27M |
| 2 |
JBGS
JBG SMITH
JBGS
|
$778K |
| 3 |
Aclaris Therapeutics
ACRS
|
$453K |
| 4 |
Indaptus Therapeutics
INDP
|
$318K |
| 5 |
Ares Capital
ARCC
|
$273K |
Sector Composition
| 1 | Healthcare | 69.43% |
| 2 | Financials | 8.02% |
| 3 | Materials | 0.26% |
| 4 | Technology | 0.23% |
| 5 | Consumer Discretionary | 0.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
TransDigm Group
TDG
$72.2B
| $208K | 0.19% |
+458
| New | +$208K |
|
|
27
Indaptus Therapeutics
INDP
$5.4M
| – | – |
-19
| Closed | -$318K |
|
|
JBGS
28
JBG SMITH
JBGS
$1.35B
| – | – |
-22,349
| Closed | -$778K |
|
|
MRNS
29
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| – | – |
-15,361
| Closed | -$176K |
|
|
30
Aclaris Therapeutics
ACRS
$221M
| – | – |
-61,264
| Closed | -$453K |
|
|
31
Ares Capital
ARCC
$15.8B
| – | – |
-17,553
| Closed | -$273K |
|